Brain Tumor Drugs Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Chemotherapy, Immunotherapy, and Others), By Indication (Pituitary, Meningioma, Glioma, and Others), By Distribution Channel (Hospital Pharmacy and Retail & Online Pharmacy), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI105025

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2024
Estimated Year	2025
Forecast Period	2025-2032
Historical Period	2019-2023
Growth Rate	CAGR of 9.8% from 2025-2032
Unit	Value (USD Billion)
Segmentation	By Therapy Targeted Therapy Chemotherapy Immunotherapy Others By Indication Pituitary Meningioma Glioma Others By Distribution Channel Hospital Pharmacy Retail & Online Pharmacy By Region North America (By Therapy, By Indication, By Distribution Channel, and By Country) U.S. (By Indication) Canada (By Indication) Europe (By Therapy, By Indication, By Distribution Channel, and By Country) U.K. (By Indication) Germany (By Indication) France (By Indication) Italy (By Indication) Spain (By Indication) Rest of Europe (By Indication) Asia Pacific (By Therapy, By Indication, By Distribution Channel, and By Country) China (By Indication) Japan (By Indication) India (By Indication) Australia (By Indication) Southeast Asia (By Indication) Rest of Asia Pacific (By Indication) Latin America (By Therapy, By Indication, By Distribution Channel, and By Country) Brazil (By Indication) Mexico (By Indication) Rest of Latin America (By Indication) Middle East & Africa (By Therapy, By Indication, By Distribution Channel, and By Country) GCC (By Indication) South Africa (By Indication) Rest of Middle East & Africa (By Indication)